GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,338,000 | +15.4% | 75,700 | 0.0% | 0.09% | +16.2% |
| Q3 2021 | $2,892,000 | +416.4% | 75,700 | +382.2% | 0.07% | +428.6% |
| Q1 2021 | $560,000 | +0.7% | 15,700 | +4.0% | 0.01% | 0.0% |
| Q4 2020 | $556,000 | -2.8% | 15,100 | -0.7% | 0.01% | -50.0% |
| Q3 2020 | $572,000 | +1261.9% | 15,200 | +1358.7% | 0.03% | +600.0% |
| Q3 2017 | $42,000 | -96.0% | 1,042 | -95.8% | 0.00% | -96.0% |
| Q2 2017 | $1,062,000 | -41.2% | 24,618 | -42.5% | 0.10% | -41.6% |
| Q1 2017 | $1,805,000 | – | 42,817 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |